Jane Street’s Seres Therapeutics MCRB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-29,905
Closed -$445K 12419
2025
Q4
$445K Sell
29,905
-38,195
-56% -$666K ﹤0.01% 7958
2025
Q3
$1.31M Buy
+68,100
New +$1.09M ﹤0.01% 5754
2023
Q4
Sell
-49,365
Closed -$2.35M 9555
2023
Q3
$2.35M Buy
49,365
+2,135
+5% +$163K ﹤0.01% 3786
2023
Q2
$4.52M Buy
+47,230
New +$5.14M ﹤0.01% 2897
2023
Q1
Sell
-3,585
Closed -$402K 9557
2022
Q4
$402K Buy
3,585
+2,360
+193% +$316K ﹤0.01% 6521
2022
Q3
$157K Buy
+1,225
New +$125K ﹤0.01% 8367
2022
Q2
Sell
-705
Closed -$100K 10399
2022
Q1
$100K Sell
705
-3,255
-82% -$501K ﹤0.01% 9457
2021
Q4
$660K Buy
3,960
+1,465
+59% +$233K ﹤0.01% 6749
2021
Q3
$347K Sell
2,495
-4,780
-66% -$935K ﹤0.01% 7912
2021
Q2
$3.47M Buy
7,275
+470
+7% +$198K ﹤0.01% 3295
2021
Q1
$2.8M Buy
6,805
+2,960
+77% +$1.36M ﹤0.01% 3386
2020
Q4
$1.88M Buy
3,845
+815
+27% +$477K ﹤0.01% 3591
2020
Q3
$1.72M Buy
+3,030
New +$1.01M ﹤0.01% 3277

Other funds holding MCRB

Jane Street's MCRB Position: Q1 2025 in Review

Jane Street sold out of Seres Therapeutics (MCRB) in Q1 2025, closing a stake of 2,937 shares — an estimated $48.8K sold.

Jane Street first reported a position in MCRB in Q2 2019 and held it in 21 quarters. The position peaked at $2.24M in Q2 2021. 63 funds tracked by Wall St. Rank hold MCRB as of Q1 2025.

  • Jane Street reported no remaining Seres Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Jane Street sold 2,937 Seres Therapeutics shares in Q1 2025, an estimated $48.8K.
  • Jane Street first reported a position in Seres Therapeutics in Q2 2019 and held it in 21 quarters.
  • Jane Street's Seres Therapeutics position peaked at $2.24M in Q2 2021.
  • 63 funds tracked by Wall St. Rank held Seres Therapeutics as of Q1 2025.

Based on Jane Street's 13F filing for Q1 2025, filed 14 May 2025.